Status
Terminated
Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.
Status
Terminated
Classification
Class I
Report Date
June 19, 2013
Termination Date
October 1, 2019